---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001198"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2026-07-17T20:34:51+00:00"
generated_at: "2026-07-17T20:36:06.981377+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences shareholders approve increase in authorized shares and share issuance at 2026 annual meeting

## Summary
- Three Class III directors re-elected: Reyes (179,416 for), Favorito (176,821), Gorgas (171,567); broker non-votes 937,382.
- Amendment to increase authorized common stock from 166,666,667 to 500,000,000 approved: 985,717 for, 164,845 against, 21,641 abstain.
- Share issuance >20% under Equity Purchase Agreement with Square Gate Capital Master Fund approved: 91,158 for, 65,155 against, 78,508 abstain, 937,382 broker non-votes.
- Approximately 41.2% of outstanding shares (1,172,203 of 2,848,540) represented at the meeting.

## SEC filing metadata
- accession: 0001640334-26-001198
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2026-07-17T20:34:51+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033426001198/0001640334-26-001198-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033426001198/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001198
- JSON: https://secwatch.observer/filing/0001640334-26-001198.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001198.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.